CN1624094A - 辛夷(望春花)油 - Google Patents
辛夷(望春花)油 Download PDFInfo
- Publication number
- CN1624094A CN1624094A CN 200410060580 CN200410060580A CN1624094A CN 1624094 A CN1624094 A CN 1624094A CN 200410060580 CN200410060580 CN 200410060580 CN 200410060580 A CN200410060580 A CN 200410060580A CN 1624094 A CN1624094 A CN 1624094A
- Authority
- CN
- China
- Prior art keywords
- oil
- flos magnoliae
- lily magnolia
- flower bud
- bud
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000218378 Magnolia Species 0.000 title abstract description 4
- 238000010438 heat treatment Methods 0.000 claims abstract description 4
- 239000012535 impurity Substances 0.000 claims abstract 2
- 241000218394 Magnolia liliiflora Species 0.000 claims description 64
- 241000628997 Flos Species 0.000 claims description 58
- 239000003921 oil Substances 0.000 claims description 33
- 239000000341 volatile oil Substances 0.000 claims description 22
- 150000001875 compounds Chemical class 0.000 claims description 20
- PEUUVVGQIVMSAW-RZTYQLBFSA-N (+)-Eudesmin Chemical compound C1=C(OC)C(OC)=CC=C1[C@@H]1[C@@H](CO[C@@H]2C=3C=C(OC)C(OC)=CC=3)[C@@H]2CO1 PEUUVVGQIVMSAW-RZTYQLBFSA-N 0.000 claims description 9
- AWOGQCSIVCQXBT-LATRNWQMSA-N (+)-Fargesin Natural products C1=C(OC)C(OC)=CC=C1[C@H]1[C@@H](CO[C@@H]2C=3C=C4OCOC4=CC=3)[C@@H]2CO1 AWOGQCSIVCQXBT-LATRNWQMSA-N 0.000 claims description 9
- PEUUVVGQIVMSAW-UHFFFAOYSA-N Diaeudesmin Natural products C1=C(OC)C(OC)=CC=C1C1C(COC2C=3C=C(OC)C(OC)=CC=3)C2CO1 PEUUVVGQIVMSAW-UHFFFAOYSA-N 0.000 claims description 9
- AWOGQCSIVCQXBT-LYDRAKHJSA-N Fargesin Chemical compound C1=C(OC)C(OC)=CC=C1[C@@H]1[C@H](CO[C@H]2C=3C=C4OCOC4=CC=3)[C@H]2CO1 AWOGQCSIVCQXBT-LYDRAKHJSA-N 0.000 claims description 9
- FDABVSXGAMFQQH-XZWHSSHBSA-N berbamunine Chemical compound CN1CCC2=CC(OC)=C(O)C=C2[C@H]1CC1=CC=C(O)C(OC2=CC=C(C=C2)C[C@@H]2N(C)CCC=3C=C(C(=CC=32)O)OC)=C1 FDABVSXGAMFQQH-XZWHSSHBSA-N 0.000 claims description 9
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 claims description 9
- -1 flavonol glycosides Chemical class 0.000 claims description 9
- 235000011957 flavonols Nutrition 0.000 claims description 9
- 229930182470 glycoside Natural products 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- AWOGQCSIVCQXBT-UHFFFAOYSA-N methyl piperitol Natural products C1=C(OC)C(OC)=CC=C1C1C(COC2C=3C=C4OCOC4=CC=3)C2CO1 AWOGQCSIVCQXBT-UHFFFAOYSA-N 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 206010061218 Inflammation Diseases 0.000 claims description 8
- 238000000605 extraction Methods 0.000 claims description 7
- 230000004054 inflammatory process Effects 0.000 claims description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 241000218377 Magnoliaceae Species 0.000 claims description 5
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 5
- 201000010099 disease Diseases 0.000 claims description 5
- 238000000926 separation method Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 230000003266 anti-allergic effect Effects 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 238000000638 solvent extraction Methods 0.000 claims description 3
- 235000019504 cigarettes Nutrition 0.000 claims description 2
- 239000002537 cosmetic Substances 0.000 claims description 2
- 230000036541 health Effects 0.000 claims description 2
- 238000003672 processing method Methods 0.000 claims description 2
- 230000000391 smoking effect Effects 0.000 claims description 2
- 239000002244 precipitate Substances 0.000 claims 1
- 239000000047 product Substances 0.000 claims 1
- 230000008901 benefit Effects 0.000 abstract description 3
- 239000002904 solvent Substances 0.000 abstract description 3
- 239000003205 fragrance Substances 0.000 abstract 1
- 239000013558 reference substance Substances 0.000 description 28
- 239000000463 material Substances 0.000 description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 241000196324 Embryophyta Species 0.000 description 9
- 238000012360 testing method Methods 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 238000005160 1H NMR spectroscopy Methods 0.000 description 5
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 description 5
- 240000005819 Magnolia denudata Species 0.000 description 5
- 235000016094 Magnolia denudata Nutrition 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 5
- DEDOPGXGGQYYMW-UHFFFAOYSA-N molinate Chemical compound CCSC(=O)N1CCCCCC1 DEDOPGXGGQYYMW-UHFFFAOYSA-N 0.000 description 5
- 230000003595 spectral effect Effects 0.000 description 5
- 238000004809 thin layer chromatography Methods 0.000 description 5
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 4
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 230000003292 diminished effect Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229960001340 histamine Drugs 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- PIRWNASAJNPKHT-SHZATDIYSA-N pamp Chemical compound C([C@@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)N)C(C)C)C1=CC=CC=C1 PIRWNASAJNPKHT-SHZATDIYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 241000007358 Magnolia biondii Species 0.000 description 1
- 241000007370 Magnolia sprengeri Species 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200410060580XA CN1304542C (zh) | 2004-10-12 | 2004-10-12 | 辛夷(望春花)油 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200410060580XA CN1304542C (zh) | 2004-10-12 | 2004-10-12 | 辛夷(望春花)油 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1624094A true CN1624094A (zh) | 2005-06-08 |
CN1304542C CN1304542C (zh) | 2007-03-14 |
Family
ID=34764332
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200410060580XA Active CN1304542C (zh) | 2004-10-12 | 2004-10-12 | 辛夷(望春花)油 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1304542C (zh) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1837392A1 (fr) * | 2006-03-21 | 2007-09-26 | Chanel Parfums Beauté | Huile de magnolia champaca, son procédé d'obtention, et compositions la contenant |
WO2007107856A1 (en) * | 2006-03-21 | 2007-09-27 | Chanel Parfums Beaute | Magnolia champaca oil, its process of preparation and compositions comprising it |
JP2011102272A (ja) * | 2009-11-11 | 2011-05-26 | Shiseido Co Ltd | Tie2活性化剤、血管の成熟化、正常化又は安定化剤、リンパ管安定化剤並びにしわ防止・改善剤及びむくみ改善・予防剤 |
CN102372721A (zh) * | 2010-08-26 | 2012-03-14 | 苏州宝泽堂医药科技有限公司 | 一种木兰脂素的制备方法 |
WO2012101746A1 (ja) * | 2011-01-24 | 2012-08-02 | 株式会社資生堂 | Tie2活性化剤、血管の成熟化、正常化又は安定化剤、リンパ管安定化剤並びにしわ防止・改善剤及びむくみ改善・予防剤 |
CN103040805A (zh) * | 2012-12-28 | 2013-04-17 | 上海中医药大学 | 辛夷脂素的医药用途 |
CN103525557A (zh) * | 2013-09-25 | 2014-01-22 | 广西芳香植物开发应用有限公司 | 玉兰花香气物质提取前的生态养花方法 |
EP2962679A1 (de) * | 2014-06-30 | 2016-01-06 | Symrise AG | Verwendung von Tetrahydrofuranlignanen |
CN106632378A (zh) * | 2016-12-23 | 2017-05-10 | 上海中医药大学 | 一种可抑制肥大细胞脱颗粒的化合物及其制备方法和用途 |
CN108367040A (zh) * | 2015-10-07 | 2018-08-03 | 株式会社冲绳研究中心 | 包含木兰花提取物、其分离物、或从其中分离的化合物作为活性成分的用于促进牙周组织生长和用于牙周炎的预防和治疗的药物组合物 |
CN111826234A (zh) * | 2019-04-16 | 2020-10-27 | 江苏苏中药业集团股份有限公司 | 一种桂枝辛夷混合挥发油的提取方法 |
CN114557933A (zh) * | 2022-03-09 | 2022-05-31 | 上海珈凯生物科技有限公司 | 一种望春花花提取物及其制备方法和应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0253896A (ja) * | 1988-08-17 | 1990-02-22 | Nippon Oil & Fats Co Ltd | ホホバ油の精製法 |
CN1116396C (zh) * | 2000-06-13 | 2003-07-30 | 芦建仁 | 天女木兰油 |
CN1493675A (zh) * | 2003-09-10 | 2004-05-05 | 恒 李 | 辛夷油提取工艺 |
CN1242762C (zh) * | 2003-09-18 | 2006-02-22 | 江苏扬子江药业集团有限公司 | 一种治疗急、慢性鼻炎的中药复方喷雾剂及其制备方法 |
-
2004
- 2004-10-12 CN CNB200410060580XA patent/CN1304542C/zh active Active
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007107856A1 (en) * | 2006-03-21 | 2007-09-27 | Chanel Parfums Beaute | Magnolia champaca oil, its process of preparation and compositions comprising it |
EP1837392A1 (fr) * | 2006-03-21 | 2007-09-26 | Chanel Parfums Beauté | Huile de magnolia champaca, son procédé d'obtention, et compositions la contenant |
JP2011102272A (ja) * | 2009-11-11 | 2011-05-26 | Shiseido Co Ltd | Tie2活性化剤、血管の成熟化、正常化又は安定化剤、リンパ管安定化剤並びにしわ防止・改善剤及びむくみ改善・予防剤 |
CN102372721A (zh) * | 2010-08-26 | 2012-03-14 | 苏州宝泽堂医药科技有限公司 | 一种木兰脂素的制备方法 |
WO2012101746A1 (ja) * | 2011-01-24 | 2012-08-02 | 株式会社資生堂 | Tie2活性化剤、血管の成熟化、正常化又は安定化剤、リンパ管安定化剤並びにしわ防止・改善剤及びむくみ改善・予防剤 |
CN103040805B (zh) * | 2012-12-28 | 2014-04-09 | 上海中医药大学 | 辛夷脂素的医药用途 |
CN103040805A (zh) * | 2012-12-28 | 2013-04-17 | 上海中医药大学 | 辛夷脂素的医药用途 |
CN103525557A (zh) * | 2013-09-25 | 2014-01-22 | 广西芳香植物开发应用有限公司 | 玉兰花香气物质提取前的生态养花方法 |
EP2962679A1 (de) * | 2014-06-30 | 2016-01-06 | Symrise AG | Verwendung von Tetrahydrofuranlignanen |
CN108367040A (zh) * | 2015-10-07 | 2018-08-03 | 株式会社冲绳研究中心 | 包含木兰花提取物、其分离物、或从其中分离的化合物作为活性成分的用于促进牙周组织生长和用于牙周炎的预防和治疗的药物组合物 |
CN106632378A (zh) * | 2016-12-23 | 2017-05-10 | 上海中医药大学 | 一种可抑制肥大细胞脱颗粒的化合物及其制备方法和用途 |
CN111826234A (zh) * | 2019-04-16 | 2020-10-27 | 江苏苏中药业集团股份有限公司 | 一种桂枝辛夷混合挥发油的提取方法 |
CN114557933A (zh) * | 2022-03-09 | 2022-05-31 | 上海珈凯生物科技有限公司 | 一种望春花花提取物及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN1304542C (zh) | 2007-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1304542C (zh) | 辛夷(望春花)油 | |
Johnson et al. | Antipyretic, analgesic, anti-inflammatory and antioxidant activities of two major chromenes from Melicope lunu-ankenda | |
CN101928642B (zh) | 一种植物神农香菊的全草中提取分离香料和药用成分的方法 | |
CN102058678B (zh) | 一种治疗脂肪肝的药物或保健食品组合物 | |
CN104306443B (zh) | 一种油樟叶综合利用的方法 | |
CN107021947A (zh) | 金钗石斛中一个新化合物及其提取分离方法 | |
CN103554077B (zh) | 一种色酮类化合物及其制备方法和应用 | |
CN103130850B (zh) | 一种从油用牡丹籽饼粕中制备芍药苷的方法 | |
CN104086467B (zh) | 一种利用溶剂萃取法和分子蒸馏法联合制备莱菔素的方法 | |
CN101019909B (zh) | 一种超临界萃取红花的方法 | |
EP2519244A1 (en) | Extract of toona sinensis from supercritical fluid extraction for treating diabetes and metabolic diseases, the preparation method and the use thereof | |
CN205473649U (zh) | 沉香精油的蒸馏生产装置 | |
Martelli et al. | Unusual essential oils with aromatic properties—I. Volatile components of Stevia rebaudiana bertoni | |
CN116712358A (zh) | 一种用于皮肤的复方精油和含有其的药物组合物 | |
CN101318893B (zh) | 一种从八角中同时提取莽草酸和香精油的工艺 | |
CN110526888A (zh) | 一种从粗糙凤尾蕨中提取香豆素的方法 | |
Maiti et al. | Isolation of hypoglycemic phytoconstituent from Swietenia macrophylla seeds | |
CN1704086A (zh) | 獐牙菜苦苷原料药制备方法 | |
CN110204589B (zh) | 青葙子有效成分、提取方法及其在制备神经保护药物方面的应用 | |
CN113881503A (zh) | 一种具有抗炎功效的青蒿精油、白茶精油及它们的组合物 | |
CN109438406B (zh) | 一种提取自柄腺山扁豆中的色酮衍生物及其制备方法和应用 | |
CN109232602B (zh) | 一种线型呋喃香豆素类化合物及其制备方法和应用 | |
CN115399324B (zh) | 一种τ-杜松醇的制备方法及用途 | |
CN113121475B (zh) | 不饱和脂肪酸类化合物及其制备方法和应用 | |
Mwazighe | Extraction, physico-chemical characterization and stability monitoring of essential oil from matricaria recutita l grown in Selected areas in Kenya |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Henan Province Nanzhao County Hualong Xinyi Development Co., Ltd. Assignor: Li Heng Contract record no.: 2010990000306 Denomination of invention: Magnolia flower oil Granted publication date: 20070314 License type: Exclusive License Open date: 20050608 Record date: 20100521 |
|
ASS | Succession or assignment of patent right |
Owner name: HUALONG XINYI DEVELOPOMENT CO., LTD.., NANZHAO COU Free format text: FORMER OWNER: LI HENG Effective date: 20100728 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 474675 HUALONG XINYI DEVELOPOMENT CO., LTD., HUALONG SCIENCE AND TECHNOLOGY PARK, NANZHAO COUNTY, HENAN PROVINCE TO: 474650 HEDONG INDUSTRY DEVELOPMENT ZONE, NANZHAO COUNTY, HENAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20100728 Address after: Hedong Industrial Development Zone, Nanzhao County, Henan province 474650 Patentee after: Henan Province Nanzhao County Hualong Xinyi Development Co., Ltd. Address before: Hualong science and Technology Park in Henan province 474675 Hualong Nanzhao County Xinyi development limited liability company Patentee before: Li Heng |
|
TR01 | Transfer of patent right |
Effective date of registration: 20170504 Address after: Nanzhao County of Nanyang City, Henan province 474650 Taiwan Huayang Longsheng science and Technology Industrial Park Patentee after: Nanzhao Baotianman Pharmaceutical Limited Company Address before: Hedong Industrial Development Zone, Nanzhao County, Henan province 474650 Patentee before: Henan Province Nanzhao County Hualong Xinyi Development Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171115 Address after: Nanyang City, Henan province 474650 Nanzhao Taiwan Huayang Longsheng science and Technology Industrial Park Patentee after: Yang Sheng (Nan Zhao) Biological Technology Co., Ltd. Address before: Nanzhao County of Nanyang City, Henan province 474650 Taiwan Huayang Longsheng science and Technology Industrial Park Patentee before: Nanzhao Baotianman Pharmaceutical Limited Company |
|
TR01 | Transfer of patent right | ||
CP01 | Change in the name or title of a patent holder |
Address after: 474650 South Call Taiwan Huayang Longsheng Science and Technology Industrial Park, Nanyang City, Henan Province Patentee after: Henglikang Biotechnology Co., Ltd. Address before: 474650 South Call Taiwan Huayang Longsheng Science and Technology Industrial Park, Nanyang City, Henan Province Patentee before: Yang Sheng (Nan Zhao) Biological Technology Co., Ltd. |
|
CP01 | Change in the name or title of a patent holder |